STOCK TITAN
  1. Home
  2. Sec-filings
  3. ICCM
  4. [EFFECT] IceCure Medical Ltd. SEC Filing

[EFFECT] IceCure Medical Ltd. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
EFFECT
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: July 9, 2025 5:15 P.M.
Form: F-1
CIK: 0001584371
Company Name: IceCure Medical Ltd.
File Number: 333-288062

Source: View Original Filing on SEC EDGAR

Stock ICCM logo
Icecure Medical Ltd.

NASDAQ:ICCM

ICCM Rankings

#5175 Ranked by Market Cap
N/A Ranked by Dividends

ICCM Latest News

Oct 3, 2025
IceCure Medical's ProSense® Cryoablation Granted FDA Marketing Authorization for Treatment of Low-Risk Breast Cancer in Women Aged 70 and Above: Significant Development in Giving Women with Breast Cancer Minimally Invasive Care
Oct 3, 2025
IceCure Receives FDA Marketing Authorization for ProSense® Cryoablation for the Treatment of Low-Risk Breast Cancer in Women Aged 70 and Above
Sep 30, 2025
IceCure's ProSense® at the European Society of Breast Imaging Congress 2025: Unlocking De-Escalation of Care in Breast Cancer, Positive Results from 5 Independent Studies Presented
Sep 22, 2025
IceCure's ProSense® Featured at CIRSE 2025 Annual Meeting: Positive Clinical Results with Cryoablation from 4 Independent Studies Presented
Sep 18, 2025
IceCure Granted Notice of Allowance for U.S. Patent for its Next-Generation XSense™ Cryoprobes

ICCM Latest SEC Filings

Oct 3, 2025
[6-K] IceCure Medical Ltd. Current Report (Foreign Issuer)
Sep 30, 2025
[6-K] IceCure Medical Ltd. Current Report (Foreign Issuer)
Sep 15, 2025
[6-K] IceCure Medical Ltd. Current Report (Foreign Issuer)
Sep 22, 2025
[6-K] IceCure Medical Ltd. Current Report (Foreign Issuer)
Sep 22, 2025
[6-K] IceCure Medical Ltd. Current Report (Foreign Issuer)

ICCM Stock Data

68.26M
40.78M
40.6%
0.36%
1.68%
Medical Devices
Healthcare
Link
Israel
Caesarea